Essex Bio-technology Ltd.
www.essexbio.com/
Essex Bio-Technology Limited (モEssexBio Groupヤ and the モCompanyヤ) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001.The principal activities of EssexBio Group are manufacture and sale of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin. EssexBio Group is also engaged in the research and development of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects.A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and two of them were classified as State-level Category I new drugs.
Reviews of Essex Bio-technology Ltd. (0)